Bio-Techne Aktie
WKN DE: A12ENG / ISIN: US09073M1045
|
05.11.2025 13:16:41
|
Bio-Techne Corp. Q1 Profit Increases, Inline With Estimates
(RTTNews) - Bio-Techne Corp. (TECH) reported a profit for its first quarter that Increases, from the same period last year in line with the Street estimates.
The company's bottom line totaled $38.18 million, or $0.24 per share. This compares with $33.60 million, or $0.21 per share, last year.
Excluding items, Bio-Techne Corp. reported adjusted earnings of $66.03 million or $0.42 per share for the period.
Analysts on average had expected the company to earn $0.42 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 1.0% to $286.55 million from $289.45 million last year.
Bio-Techne Corp. earnings at a glance (GAAP) :
-Earnings: $38.18 Mln. vs. $33.60 Mln. last year. -EPS: $0.24 vs. $0.21 last year. -Revenue: $286.55 Mln vs. $289.45 Mln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bio-Techne Corpmehr Nachrichten
Analysen zu Bio-Techne Corpmehr Analysen
Aktien in diesem Artikel
| Bio-Techne Corp | 51,00 | 0,00% |
|